PELP1 regulation of mTOR Axis: Role in breast cancer progression and resistance

被引：0
|
作者：
Gonugunta, Vijaya Kumar [1 ]
Valerie, Cortez [1 ]
Roy, Sudipa Saha [1 ]
Sareddy, Gangadhar Reddy [1 ]
Nair, Binoj C. [1 ]
Vadlamudi, Ratna K. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-958
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
958
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The role of PELP1/MNAR in progression and metastasis of breast cancer.
    Rajhans, R.
    Nair, S. S.
    De La Pena Jr., M. O.
    Alan, H.
    Kumar, R.
    Rajeshwar, T. R.
    Vadlamudi, R. K.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S13 - S13
  • [2] Significance and therapeutic potential of PELP1-mTOR axis in breast cancer progression and therapy resistance
    Gonugunta, V. K.
    Cortez, V.
    Sareddy, G. R.
    Roy, S. S.
    Zhang, H.
    Tekmal, R. R.
    Vadlamudi, R. K.
    [J]. CANCER RESEARCH, 2012, 72
  • [3] Regulation of mTOR Signaling by Proto-Oncogene PELP1
    Gonugunta, V. K.
    Cortez, V.
    Rethman, C.
    Nair, B. C.
    Sareddy, G. R.
    Vadlamudi, R. K.
    [J]. CANCER RESEARCH, 2011, 71
  • [4] Significance of PELP1 signaling in liver cancer progression
    Pratap, Uday
    Nassar, Khaled Mohamed
    Yang, Xue
    Baker, Adriana
    Gopalam, Rahul
    Arnold, William C.
    Adeniran, Timilehin
    Hernandez Fernandez, Marian Helena
    Sareddy, Gangadhara R.
    Viswanadhapalli, Suryavathi
    Sun, Luzhe
    Vadlamudi, Ratna K.
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [5] Epigenetic regulation of microRNA-200a and 141 by proto-oncogene PELP1: Role in breast cancer progression and metastasis
    Roy, Sudipa Saha
    Rao, Manjeet
    Sun, Luzhe
    Tekmal, Rajeshwar Rao
    Vadlamudi, Ratna K.
    [J]. CANCER RESEARCH, 2012, 72
  • [6] The Role of Ser991 PELP1 Phosphorylation in Therapy Resistance and Metastasis of Breast Cancer.
    Sareddy, G. R.
    Nair, B. C.
    Krishnan, S. R.
    Gonugunta, V. K.
    Vadlamudi, R. K.
    [J]. CANCER RESEARCH, 2011, 71
  • [7] Targeting the PELP1 axis for treating ESR1 mutant driven breast cancer
    Altwegg, Kristin A.
    Viswanadhapalli, Suryavathi
    Liu, Junhao
    Liu, Zexuan
    Pratap, Uday P.
    Ebrahimi, Benham
    Vankayalapati, Hariprasad
    Vadlamudi, Ratna K.
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [8] Significance and therapeutic potential of PELP1 axis in ER-negative breast cancer
    Vadlamudi, Ratna K.
    Roy, Sudipa Saha
    [J]. CANCER RESEARCH, 2011, 71
  • [9] The role of proto-oncogene PELP1 in breast cancer stem cell maintenance and therapy resistance
    Viswanadhapalli, Suryavathi
    Mann, Monica
    Sareddy, Gangadhara Reddy
    Lix, Xaionan
    Vankayalapati, Hariprasad
    Vadlamudi, Ratna K.
    [J]. CANCER RESEARCH, 2016, 76
  • [10] SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
    Liu, Zexuan
    Liu, Junhao
    Ebrahimi, Behnam
    Pratap, Uday P.
    He, Yi
    Altwegg, Kristin A.
    Tang, Weiwei
    Li, Xiaonan
    Lai, Zhao
    Chen, Yidong
    Shen, Liangfang
    Sareddy, Gangadhara R.
    Viswanadhapalli, Suryavathi
    Tekmal, Rajeshwar R.
    Rao, Manjeet K.
    Vadlamudi, Ratna K.
    [J]. BREAST CANCER RESEARCH, 2022, 24 (01)
12345